All lobbying filings

DCI GROUP, L.L.C.

DCI GROUP, L.L.C. filed a Q4 report for VAXCYTE, INC. on January 20, 2026, reporting $75,000 in lobbying income.

Lobbying for VAXCYTE, INC. · Clinical-stage vaccine company

All filings by DCI GROUP, L.L.C. · Everything VAXCYTE, INC. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$75,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 2

Executive Office of the President (EOP)
White House Office

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

General lobbying on vaccine development issues.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.